nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer
|
Jones, Suzanne |
|
2008 |
9 |
3 |
p. 154-159 6 p. |
artikel |
2 |
Assessment of Guilt and Shame in Patients with Non–Small-Cell Lung Cancer Compared with Patients with Breast and Prostate Cancer
|
LoConte, Noelle K. |
|
2008 |
9 |
3 |
p. 171-178 8 p. |
artikel |
3 |
Gender Issues and the Molecular Epidemiology of Lung Cancer Risk
|
Lazarus, Philip |
|
2008 |
9 |
3 |
p. 140- 1 p. |
artikel |
4 |
2008 Highlights from: The IASLC-ESMO 1st European Lung Cancer Conference; Geneva, Switzerland; April 2008
|
Mack, Philip C. |
|
2008 |
9 |
3 |
p. 145-147 3 p. |
artikel |
5 |
Hypertrophic Osteoarthropathy Effectively Treated with Zoledronic Acid
|
King, Melissa M. |
|
2008 |
9 |
3 |
p. 179-182 4 p. |
artikel |
6 |
Molecular Epidemiology to Better Predict Lung Cancer Risk
|
Reid, Mary E. |
|
2008 |
9 |
3 |
p. 149-153 5 p. |
artikel |
7 |
Monoclonal Antibodies Versus Tyrosine Kinase Inhibitors Concurrent with Chemotherapy in Non–Small-Cell Lung Cancer: Exploring Divergent Results
|
Lara Jr, Primo N. |
|
2008 |
9 |
3 |
p. 141-143 3 p. |
artikel |
8 |
Phase I Study of Flavopiridol in Combination with Paclitaxel and Carboplatin in Patients with Non–Small-Cell Lung Cancer
|
George, Saby |
|
2008 |
9 |
3 |
p. 160-165 6 p. |
artikel |
9 |
Selected Clinical Trials in Non–Small-Cell Lung Cancer
|
Langer, Corey J. |
|
2008 |
9 |
3 |
p. 183-184 2 p. |
artikel |
10 |
Serum Endothelial Monocyte-Activating Polypeptide–II: A Novel Biomarker in Patients with Non–Small-Cell Lung Cancer
|
Sen, Elif |
|
2008 |
9 |
3 |
p. 166-170 5 p. |
artikel |